Correction from source: nls pharmaceutics to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest

Presentation to take place on tuesday, june 20, 2023, at 10:30am et zurich, switzerland / accesswire / june 19, 2023 / nls pharmaceutics ltd. (nasdaq: nlsp, nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that alex zwyer, chief executive officer of nls pharmaceutics will present at the healthcare virtual conference part ii, presented by maxim group llc and hosted by m-vest on tuesday, june 20, 2023, at 10:30 am et.
NLSP Ratings Summary
NLSP Quant Ranking